Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 107

Sort by

Sort Order Select

Journal Articles

Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation

Blood (2021) 137 (17): 2394–2402.

https://doi.org/10.1182/blood.2020008997

Published: 2021

Includes: Supplemental data

Journal Articles

Impact of ABO Blood Group Incompatibility on Outcomes after Single-Unit Umbilical Cord Blood Transplantation for Malignant Hematological Disease

Cheng Siqi, Baolin Tang, Xiaoyu Zhu, Huilan Liu, Kaidi Song, Xiang Wan, Wen Yao, Jian Wang, Zimin Sun

Blood (2019) 134 (Supplement_1): 2055.

https://doi.org/10.1182/blood-2019-130699

Published: 2019

Journal Articles

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Judit Rejtoe, MD, Oliver Königsbrügge, MD, Ella Grilz, MD, Stefanie Hofer, Johanna Gebhart, MD, Gerhard Schuster, MD, Clemens Feistritzer, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2019) 134 (Supplement_1): 1135.

https://doi.org/10.1182/blood-2019-123187

Published: 2019

Journal Articles

Antibody Dependent Enhancement of Infections after High Dose Chemotherapy

Jens Magnus Bernth-Jensen, MD, Bjarne Kuno Møller, MD, Steffen Thiel, PhD, Anette Tarp Hansen, MD PhD

Blood (2019) 134 (Supplement_1): 1047.

https://doi.org/10.1182/blood-2019-122236

Published: 2019

Journal Articles

Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival

Elizabeth Krieger, MD, Urmila Sivagnanaling, Katherine Webb, Dana Broadway, Catherine Roberts, PhD, John M. McCarty, MD, Christina M. Wiedl, DO, Rizwan Romee, MD PhD, Armand Keating, MD, Rehan Qayyum, Amir Ahmed Toor, MBBS

Blood (2019) 134 (Supplement_1): 4616.

https://doi.org/10.1182/blood-2019-129384

Published: 2019

Journal Articles

In-Vivo Adsorption of Iso-Haemagglutinin (IHA) Antibodies By Donor Type Red Cell Transfusion during Conditioning Is a Safe and Effective Method to Overcome Major ABO Incompatibility-Related Acute Hemolytic Reactions in Stem Cell Transplant Using Bone Marrow As Stem Cell Graft Source

Pallavi Mehta, MD DM, Stalin Ramprakash, MD MBBS, C Raghuram, Deepa Trivedi, MD, Priya Marwah, Rajpreet Soni, Rakesh Dhanya, BE, Rajat Kumar Agarwal, BS, Lawrence Faulkner, MD

Blood (2019) 134 (Supplement_1): 4467.

https://doi.org/10.1182/blood-2019-131118

Published: 2019

Journal Articles

ABO Blood Groups and the Risk of Venous Thromboembolism (VTE) Among Saudi Patients at a Tertiary Care Hospital in Riyadh

Ghaydaa Juma Kullab, MD, Abdul Rehman Z. Zaidi, MBBS, Sultan Albaqmi, Haya Alajlan, Mohammed Abdullah Alsheef, MD

Blood (2019) 134 (Supplement_1): 4926.

https://doi.org/10.1182/blood-2019-128050

Published: 2019

Journal Articles

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Laura L. Swystun, Kenichi Ogiwara, Orla Rawley, Christine Brown, Ilinca Georgescu, Wilma Hopman, Veerle Labarque, Christoph Male, Katharina Thom, Victor S. Blanchette, Manuel D. Carcao, David Lillicrap

Blood (2019) 134 (11): 880–891.

https://doi.org/10.1182/blood.2019000190

Published: 2019

Includes: Supplemental data

Journal Articles

Impact of Cytokine Release Syndrome on Outcomes after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Blood (2018) 132 (Supplement 1): 3357.

https://doi.org/10.1182/blood-2018-99-114100

Published: 2018

Journal Articles

Donor-Specific Isoagglutinin Clearance in ABO Mismatched Stem Cell Transplant Recipients: How Long Should It Normally Take?

John Chinawaeze Aneke, MBBS, FMCPath, Nayana Sondi, Santhosh Thyagu, MDDM, Christine M. Cserti-Gazdewich, BSc, MD FRCPC, Jacob Pendergrast, MDFRCPC

Blood (2018) 132 (Supplement 1): 1260.

https://doi.org/10.1182/blood-2018-99-115075

Published: 2018

Journal Articles

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Paul Lin, MD PhD, Lauren Westfall Veltri, MD, Katy Rezvani, MD PhD, Betul Oran, MD MS, Sairah Ahmed, MD, Gheath Alatrash, DO, PhD, Rohtesh S. Mehta, MD MPH, MS, Gabriela Rondon, MD, Partow Kebriaei, MD, Uday Popat, MD, Yago Nieto, MD PhD, Chitra Hosing, MD, Roy B Jones, MD PhD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, Elizabeth J. Shpall, MD, Richard E Champlin, MD, David Marin, MD

Blood (2018) 132 (Supplement 1): 4667.

https://doi.org/10.1182/blood-2018-99-112749

Published: 2018

Journal Articles

Incidence and Risk Factors for IVIG-Mediated Hemolysis

Jacob Pendergrast, MDFRCPC, Beth Binnington, MSc, Tik Nga Tong, Jeannie Callum, MD, Christine Margaret Cserti-Gazdewich, BSc, MD FRCPC, Wendy Lau, MBBS,FRCPC, Lani Lieberman, MD, Yulia Lin, MD, Katerina Pavenski, MD BSc, FRCPC, Nadine Shehata, MDFRCPC,MSc, Rae Yeung, MD PhD FRCP, Donald R. Branch, PhD

Blood (2017) 130 (Supplement 1): 2398.

https://doi.org/10.1182/blood.V130.Suppl_1.2398.2398

Published: 2017

Journal Articles

ABO Blood Type and the Risk of Cardovascular Events: An Analysis of Framingham Data and Meta-Analysis

Margaret Kasner, MD, Barbara Konkle, MD, Mark Cary, PhD, Stephen Kimmel, MDMSCE

Blood (2017) 130 (Supplement 1): 3696.

https://doi.org/10.1182/blood.V130.Suppl_1.3696.3696

Published: 2017

Journal Articles

B-RhD-Positive Blood Group Appears Relatively Less Susceptible to Anemia in Sickle Cell Disease Pregnant Women

Ogbonna Collins Nwabuko, MBBS, FMCPath, Dorathy Adaunwa Okoh, MB,ChB; FMCPath, FWACP, Christian Aluka, MBBS, MRCOG, FWACS, FICS, FRCOG

Blood (2017) 130 (Supplement 1): 4796.

https://doi.org/10.1182/blood.V130.Suppl_1.4796.4796

Published: 2017

Journal Articles

Inhibition of the Transcription Factor RUNX1 Causes Glycosyltransferase a Repression

Romy Kronstein-Wiedemann, Laura Schmidt, Jörn Lausen, Erhard Seifried, MD PhD, Torsten Tonn, MD PhD

Blood (2017) 130 (Supplement 1): 925.

https://doi.org/10.1182/blood.V130.Suppl_1.925.925

Published: 2017

Journal Articles

Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001

Uma H. Athale, MD, M.Sc., Traci M. Blonquist, MS, Kristen E. Stevenson, MS, Menachem Spira, Peter D. Cole, MD, Barbara L Asselin, MD, Luis A. Clavell, MD, Kara M. Kelly, MD, Caroline Laverdière, MDFRCPC, Jean-Marie Leclerc, MD, Bruno Michon, MD, Marshall A. Schorin, MD, Maria Luisa Sulis, MD, Jennifer J.G. Welch, MD, Marian H. Harris, MD PhD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2017) 130 (Supplement 1): 1278.

https://doi.org/10.1182/blood.V130.Suppl_1.1278.1278

Published: 2017

Journal Articles

Downregulation of Glycosyltransferase a Expression By miRNA-331-3p Is Mediated By the Inhibition of the Transcription Factor SP1

Romy Kronstein-Wiedemann, Peter Bugert, Erhard Seifried, MD PhD, Torsten Tonn, MD PhD

Blood (2016) 128 (22): 1247.

https://doi.org/10.1182/blood.V128.22.1247.1247

Published: 2016

Journal Articles

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Masaki Hayakawa, MD, Seiji Kato, PhD, Taei Matsui, PhD, Kazuya Sakai, MD, Yumi Yoshii, MD, Hideo Yagi, MD.PhD, Yoshihiro Fujimura, MD, PhD, Masanori Matsumoto, MD.PhD

Blood (2016) 128 (22): 3773.

https://doi.org/10.1182/blood.V128.22.3773.3773

Published: 2016

Journal Articles

Immunohematologic Complications after Nonmyeloablative Hematopoietic Progenitor Cell Transplantation in Patients with Sickle Cell Disease

Elizabeth S. Allen, MD, Matthew M. Hsieh, MD, Courtney D. Fitzhugh, MD, Harvey G. Klein, MD, John F. Tisdale, MD, Willy A. Flegel

Blood (2016) 128 (22): 3404.

https://doi.org/10.1182/blood.V128.22.3404.3404

Published: 2016

Journal Articles

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Nancy Robitaille, MD, Yves D. Pastore, MD, Anne-Julie Landry, M.Sc, Catherine Latour, MD, Josée Lavoie, M.Sc, Geneviève Laflamme, M.Sc, Josée Perreault, PhD, Maryse St-Louis, PhD

Blood (2016) 128 (22): 2486.

https://doi.org/10.1182/blood.V128.22.2486.2486

Published: 2016

NARROW

Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation

Impact of ABO Blood Group Incompatibility on Outcomes after Single-Unit Umbilical Cord Blood Transplantation for Malignant Hematological Disease

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Antibody Dependent Enhancement of Infections after High Dose Chemotherapy

Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival

In-Vivo Adsorption of Iso-Haemagglutinin (IHA) Antibodies By Donor Type Red Cell Transfusion during Conditioning Is a Safe and Effective Method to Overcome Major ABO Incompatibility-Related Acute Hemolytic Reactions in Stem Cell Transplant Using Bone Marrow As Stem Cell Graft Source

ABO Blood Groups and the Risk of Venous Thromboembolism (VTE) Among Saudi Patients at a Tertiary Care Hospital in Riyadh

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Impact of Cytokine Release Syndrome on Outcomes after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Donor-Specific Isoagglutinin Clearance in ABO Mismatched Stem Cell Transplant Recipients: How Long Should It Normally Take?

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Incidence and Risk Factors for IVIG-Mediated Hemolysis

ABO Blood Type and the Risk of Cardovascular Events: An Analysis of Framingham Data and Meta-Analysis

B-RhD-Positive Blood Group Appears Relatively Less Susceptible to Anemia in Sickle Cell Disease Pregnant Women

Inhibition of the Transcription Factor RUNX1 Causes Glycosyltransferase a Repression

Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001

Downregulation of Glycosyltransferase a Expression By miRNA-331-3p Is Mediated By the Inhibition of the Transcription Factor SP1

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Immunohematologic Complications after Nonmyeloablative Hematopoietic Progenitor Cell Transplantation in Patients with Sickle Cell Disease

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only